Citation
64 FR 4112
Multiple canonical documents share this first-page citation.
- Agency Information Collection Activities; Announcement of OMB Approval; Guidance for Industry: Current Good Manufacturing Practice for Blood and Blood Components: (1) Quarantine and Disposition of Units From Prior Collections From Donors with Repeatedly Reactive Screening Test for Antibody to Hepatitis C Virus (Anti-HCV); (2) Supplemental Testing, and the Notification of Consignees and Blood Recipients of Donor Test Results for Anti-HCV 64 FR 4112
- Agency Information Collection Activities; Submission for OMB Review; Comment Request; Premarket Approval of Medical Devices 64 FR 4112